Tada Hiroshi

タダヒロシ | Tada Hiroshi

Affiliation and department：
Job title： Associate Professor
Homepage URL (1)： https://www.med.tohoku.ac.jp/about/laboratory/030.html

Research field (3)： General surgery, pediatric surgery , Tumor diagnostics and therapeutics , Nanobioscience

Research theme for competitive and other funds (19)：

2022 - 2025 放射線治療に有用なアブスコパル効果の発現機序解明と応用
2022 - 2025 プロテオーム・メタボローム解析による乳癌の新規悪性度評価と代謝標的治療効果予測
2022 - 2025 呼気オミックスを用いた乳がん口腔支援システムの開発
2022 - 2025 非標準的遺伝子四重鎖への効果的薬剤送達を基盤とする新規光線力学療法の開発
2019 - 2022 重症下肢虚血における組織障害因子の解明と新たな救肢治療法の開発

2019 - 2022 Development of early-stage cancer detection method and radiotherapy using ultra-small gold nanoparticles

2018 - 2021 Development of predictive oral supportive system for perioperative breast cancer patients

2017 - 2021 Clinical significance of ABCG2/BCRP quantified by fluorescence nanoparticle in breast cancer patients undergoing neoadjuvant chemotherapy

2017 - 2021 Development and application of new gastrointestinal fluorescent clip system which can be detected from outside

2015 - 2019 Elucidation of infiltration and propagation mechanism of breast cancer bone metastasis using multimodal imaging

2015 - 2017 Quantitative evaluation of estrogen receptor and the validation for breast cancer by nano particle-based immunohistochemistry

2014 - 2017 quantitative diagnosis of Breast cancer stemness-related protein by single particle nano imaging

2013 - 2017 Basic construction for treatment effect prediction of molecular targeted drugs by quantitative estimation of HER family receptor based on highly sensitive nanoparticle imaging

2014 - 2016 X-ray computed tomography imaging of a tumor with high sensitivity

2012 - 2015 Development of a diagnostic method for epigenetic posttranslational modifications of histone using fluorescence imaging

2012 - 2014 Correlation between late recurrence in breast cancer and breast cancer stem cell using fluorescence nano-particle

2011 - 2012 Development of an innovative method for evaluating DDS formulationpharmacokinetics by using multi-photon excitation microscopy

2009 - 2010 Role of ESCRT system in triple negative breast cancer

2008 - 2010 A case-control study of breast cancer in relation to the risk for estrogen levels in breast tissue and in situ estrogen production

Show all

Papers (120)：

Yuechen Wang, Narumi Harada-Shoji, Narufumi Kitamura, Yuto Yamazaki, Akiko Ebata, Masakazu Amari, Mika Watanabe, Minoru Miyashita, Hiroshi Tada, Takaaki Abe, et al. Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer. Cancer medicine. 2024. 13. 2. e6987
Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, et al. Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. 2023
Akiko Ebata, Takashi Suzuki, Narumi Shoji-Harada, Yohei Hamanaka, Minoru Miyashita, Erina Iwabuchi, Kiyoshi Takagi, Yasuhiro Miki, Hiroshi Tada, Takanori Ishida. Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor. Acta histochemica et cytochemica. 2023. 56. 4. 59-66
増田紘子, 多田寛, 服部正也, 古川孝広, 原文堅, 田辺裕子, 相良安昭, 北川大, 枝園忠彦, 岩谷胤生, et al. がんゲノム徹底討論! 乳癌における包括的ゲノム診療の実際 JBCRG REIWA studyを通して. 日本乳癌学会総会プログラム抄録集. 2023. 31回. 28-28
森下葵, 多田寛, 宮下穣, 原田成美, 濱中洋平, 江幡明子, 柳垣美歌, 佐藤未来, 山崎あすみ, 井上千裕, et al. 乳癌の術後補助療法選択においてMammaPrint/BluePrintを実施した一例. 東北医学雑誌. 2023. 135. 1. 35-38

ｍore...

MISC (326)：

濱中洋平, 多田寛, 赤松大二朗, 石井正, 内藤剛, 海野倫明, 亀井尚, 石田孝宣. 「地域を守り、地域で生きる外科医たちの思い」東北地方における地域の夜間・休日救急診療での外科医の役割と課題. 日本外科学会雑誌. 2021. 122. 2. 230-232
照井洋輔, 杉村宏一郎, 大田英揮, 多田寛, 勝田祐子, 佐藤遥, 後岡広太郎, 建部俊介, 宮田敏, 坂田泰彦, et al. Usefulness of Native T1 Mapping for Prediction of Chemotherapeutics-related Cardiac Dysfunction in Breast Cancer Patients(和訳中). 日本循環器学会学術集会抄録集. 2021. 85回. OJ29-5
Yutaka Yamamoto, Hiroji Iwata, Taira Naruto, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, et al. A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study. CANCER RESEARCH. 2021. 81. 4
進藤晴彦, 原田成美, 多田寛, 宮下穣, 濱中洋平, 佐藤章子, 江幡明子, 本成登貴和, 金井綾子, 柳垣美歌, et al. 内分泌療法耐性乳癌における代謝の変化. 日本外科学会定期学術集会(Web). 2021. 121st
江幡明子, 多田寛, 宮下穣, 原田成美, 佐藤章子, 濱中洋平, 深町佳世子, 佐藤未来, 金井綾子, 本成登貴和, et al. BRACAnalysis保険適用後の現状と問題点. 日本外科学会定期学術集会(Web). 2021. 121st

ｍore...

Books (4)：

Professional management;technique for;adverse events of;breast cancer systemic therapy
2021
日本臨牀増刊号乳癌(第2版) 基礎と臨床の再診研究動向
Nippon Rinsho 2012
Nano-Biomedical Engineering 2012 : Proceedings of the Tohoku University Global Centre of Excellence Programme
Imperial College Press 2011
Nano-Biomedical Engineering 2012 : Proceedings of the Tohoku University Global Centre of Excellence Programme "Global Nano-Biomedical Engineering Education and Research Network Centre"
Imperial College Press 2011

Lectures and oral presentations (286)：

Usefulness of Native T1 Mapping for Prediction of Chemotherapeutics-related Cardiac Dysfunction in Breast Cancer Patients(和訳中)
(日本循環器学会学術集会抄録集 2021)
乳癌におけるがん遺伝子パネル検査の問題点とその対応についての検討
(日本乳癌学会総会プログラム抄録集 2020)
エストロゲン受容体の発現を制御するFbxo22は浸潤性小葉癌の予後因子となりうるか
(日本乳癌学会総会プログラム抄録集 2020)
BRACAnalysis施行症例の検討
(日本乳癌学会総会プログラム抄録集 2020)
メタボローム解析を用いた乳癌サブタイプ別代謝プロファイルの解明と新規標的の可能性
(日本乳癌学会総会プログラム抄録集 2020)

ｍore...

Professional career (1)：

M.D., Ph.D (Tohoku University)

Association Membership(s) (5)：

American Association for Cancer Research (AACR) , AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) , Society of Nano Science and Technology , JAPAN SURGICAL ASSOCIATION , 日本緩和医療学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page